K. Katano et al., Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer, ONCOL REP, 8(3), 2001, pp. 605-609
Intraoperative intrapleural (i.pl.) cisplatin (CDDP) treatment during thora
cotomy was performed for esophageal cancers. Three patients underwent isoto
nic (308 mOsm/1) CDDP treatment. Hypotonic CDDP treatments with a 154 mOsm/
1 solution and a 62 mOsm/1 solution were administered to 4 and 9 patients,
respectively. The maximum concentrations (C-max) of both total and filterab
le platinum in the plasma after injection of the hypotonic solution were si
gnificantly higher than those after injection of the isotonic solution. The
area under the curve of concentration versus time (AUC) of the plasma of t
he 62 mOsm/1 solution was significantly higher than that of the 154 mOsm/1
and isotonic solution. Although higher levels of the C-max may increase sid
e-effects, the hypotonic condition of the i.pl. fluid and increased AUC in
the plasma may escalate the accumulation of platinum in i.pl. cancer cells.
These results suggest that hypotonic i.pl. CDDP is tolerable and may be us
eful for treatment of the incipient phase of pleural carcinomatosis and for
prophylaxis of postoperative recurrence.